Susquehanna International Group’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-384,293
| Closed | -$276K | – | 7254 |
|
2025
Q1 | $276K | Buy |
384,293
+269,265
| +234% | +$193K | ﹤0.01% | 5118 |
|
2024
Q4 | $128K | Buy |
+115,028
| New | +$128K | ﹤0.01% | 5567 |
|
2024
Q3 | – | Sell |
-247,167
| Closed | -$247K | – | 6609 |
|
2024
Q2 | $247K | Buy |
247,167
+220,586
| +830% | +$221K | ﹤0.01% | 4453 |
|
2024
Q1 | $63K | Sell |
26,581
-36,998
| -58% | -$87.7K | ﹤0.01% | 5130 |
|
2023
Q4 | $143K | Buy |
63,579
+10,738
| +20% | +$24.2K | ﹤0.01% | 5185 |
|
2023
Q3 | $112K | Sell |
52,841
-16,668
| -24% | -$35.3K | ﹤0.01% | 4875 |
|
2023
Q2 | $215K | Sell |
69,509
-261,454
| -79% | -$808K | ﹤0.01% | 4587 |
|
2023
Q1 | $1.78M | Buy |
330,963
+283,066
| +591% | +$1.52M | ﹤0.01% | 2105 |
|
2022
Q4 | $319K | Buy |
+47,897
| New | +$319K | ﹤0.01% | 3823 |
|
2022
Q3 | – | Sell |
-53,074
| Closed | -$264K | – | 6947 |
|
2022
Q2 | $264K | Buy |
+53,074
| New | +$264K | ﹤0.01% | 4162 |
|
2022
Q1 | – | Sell |
-12,360
| Closed | -$144K | – | 6580 |
|
2021
Q4 | $144K | Buy |
+12,360
| New | +$144K | ﹤0.01% | 5153 |
|